(Q34805912)

English

Azithromycin and loperamide are comparable to levofloxacin and loperamide for the treatment of traveler's diarrhea in United States military personnel in Turkey

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Azithromycin and loperamide are comparable to levofloxacin and loperamide for the treatment of traveler's diarrhea in United States military personnel in Turkey (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

0 references

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Shannon D Putnam

3

object named as

Shannon D Putnam

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

4

object named as

Mark S Riddle

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

David R Tribble

9

object named as

David R Tribble

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

David M Rockabrand

7

object named as

David M Rockabrand

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

author name string

John W Sanders

1

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Robert W Frenck

2

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

James R Johnston

5

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Sefa Ulukan

6

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Marshall R Monteville

8

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

language of work or name

0 references

publication date

1 August 2007

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

45

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

294-301

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Epidemiology of traveler's diarrhea

1 reference

https://api.crossref.org/works/10.1086%2F519264

21 January 2018

Empirical antimicrobial therapy for traveler's diarrhea

1 reference

https://api.crossref.org/works/10.1086%2F519264

21 January 2018

Update in traveler's diarrhea

1 reference

https://api.crossref.org/works/10.1086%2F519264

21 January 2018

Prevention and self-treatment of traveler's diarrhea

1 reference

https://api.crossref.org/works/10.1086%2F519264

21 January 2018

Travellers' diarrhoea: contemporary approaches to therapy and prevention

1 reference

https://api.crossref.org/works/10.1086%2F519264

21 January 2018

Rifaximin: a novel nonabsorbed rifamycin for gastrointestinal disorders

1 reference

https://api.crossref.org/works/10.1086%2F519264

21 January 2018

Campylobacter, from obscurity to celebrity

1 reference

https://api.crossref.org/works/10.1086%2F519264

21 January 2018

Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years

1 reference

https://api.crossref.org/works/10.1086%2F519264

21 January 2018

Single dose of azithromycin or three-day course of ciprofloxacin as therapy for epidemic dysentery in Kenya. Acute Dysentery Study Group

1 reference

https://api.crossref.org/works/10.1086%2F519264

21 January 2018

Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent.

1 reference

https://api.crossref.org/works/10.1086%2F519264

21 January 2018

Azithromycin found to be comparable to levofloxacin for the treatment of US travelers with acute diarrhea acquired in Mexico

1 reference

https://api.crossref.org/works/10.1086%2F519264

21 January 2018

Traveler's diarrhea in Thailand: randomized, double-blind trial comparing single-dose and 3-day azithromycin-based regimens with a 3-day levofloxacin regimen

1 reference

https://api.crossref.org/works/10.1086%2F519264

21 January 2018

Posttreatment changes in Escherichia coli antimicrobial susceptibility rates among diarrheic patients treated with ciprofloxacin

1 reference

https://api.crossref.org/works/10.1086%2F519264

21 January 2018

"Proving the null hypothesis" in clinical trials

1 reference

https://api.crossref.org/works/10.1086%2F519264

21 January 2018

Self-reported description of diarrhea among military populations in operations Iraqi Freedom and Enduring Freedom

1 reference

https://api.crossref.org/works/10.1086%2F519264

21 January 2018

Ciprofloxacin- and azithromycin-resistant Campylobacter causing traveler's diarrhea in U.S. troops deployed to Thailand in 1994.

1 reference

https://api.crossref.org/works/10.1086%2F519264

21 January 2018

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34805912&oldid=1762666981"